FDA Approves First Two-Drug Once-Daily Single-Pill HIV Regimen
On November 21, 2017, the U.S. Food and Drug Administration (FDA) approved the first-ever two-drug once-daily single-pill regimen for the maintenance treatment of adults...
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
ViiV’s Dolutegravir Dual Therapy Works for Both First-Line & Maintenance Treatment
Findings from the GEMINI and TANGO studies, reported at the 10th International AIDS Society...
REPRIEVE Study
Protecting One's Heart
The REPRIEVE study aims to prevent cardiovascular disease
by Chael Needle
As people are living longer with HIV, researchers have been increasingly attending to...
Optimal ARTs for Older Adults with HIV
Optimal ARTs for Older Adults with HIV
Recently, the HIV-Age.org website published the results of a review to identify the most effective, least toxic ART...
Undetectable = Untransmittable Reconfirmed by New Study, Embraced at IAS 2017
A newly completed study of 358 serodiscordant gay couples has not found a single case of HIV transmission in 16,889 acts of condomless anal...
Fat Chance
A Treatment for Lipodystrophy-Related Excessive Abdominal Fat Comes of Age
by Chael Needle
HIV-associated lipodystrophy, abnormalities in metabolism and/or distribution of fat in those living with...
Skin Cancers Revisited
Sun Blocked
A new study examines non-melanoma skin cancers & HIV
by Chael Needle
In the pre-HAART era, an AIDS diagnosis or even an HIV-positive diagnosis illuminated...
The Road Ahead
LifeGuide
Treatment Horizons
The Road Ahead
New candidates hold promise for ARV therapy & therapeutic vaccines
by Mariel Selbovitz, MPH
The 54th Interscience Conference on Antimicrobial Agents and Chemotherapy...
Verve for VERxVE
An extended release formulation breaks through
by Chael Needle
Based on results from the VERxVE study, the FDA recently approved Viramune XR for use in antiretroviral...
CDC Announces: More people with HIV have the virus under control
On July 26, 2017, the Centers for Disease Control and Prevention released new data on the nation’s progress in HIV testing and treatment, showing...